Canine Epilepsy Website

Canine Epilepsy Network

Initial funding for creation of this Website was provided by the Committee on Research, College of Veterinary Medicine, University of Missouri-Columbia. The site is provided as a resource for all those concerned with canine epilepsy: owners and breeders of affected dogs, veterinarians, neurologists, and researchers. The Canine Epilepsy Research Consortium is a group of scientists from the Animal Health Trust in the UK and a number of American Universities including Missouri, Minnesota, and Ohio State who are collaborating to:

• share DNA samples, phenotype data, and genotype data.

• share credit for scientific contribution by co-authoring manuscripts.

• put discoveries into the public domain.

This site has an active discussion forum policed by neurology specialists. Another useful feature is the searchable database of neurology specialists in the USA allowing owners and veterinarians to identify a specialist in their area. For information on neurology specialists in the UK. Visit the Site Here

Vetstream Ltd

Vetstream Ltd is a leading provider of comprehensive, peer-reviewed clinical information services to the world-wide veterinary market. Its revolutionary information services, Canis, Felis, Equis and Lapis, support veterinarians from presenting problems and diagnosis to selecting treatment – helping them save valuable time, deliver the highest level of patient care and facilitate client communication.

Vetstream’s comprehensive, peer-reviewed, clinical information services:
•		cover all body systems and disciplines
•		are enhanced with interactive pictures, radiographs, heart sounds and videos of diagnostic and surgical techniques
•		are up-to-date, easy to use and fully cross-referenced
•		provide information from over 300 leading clinicians
•		are used regularly by veterinary professionals in over 60 countries worldwide including approximately 40% of UK practices.

Vetstream Ltd, Three Hills Farm, Bartlow, Cambridge CB1 6EN, UK
t: +44 (0) 1223 895818 f: +44 (0) 1223 895819
e: enquiries@vetstream.com
w: www.vetstream.co.uk

Vetoquinol

Vetoquinol was originally a family business set up in 1933. The Vétoquinol name was created in 1952. The Vétoquinol Group is entirely turned towards the future and devotes all its efforts to searching for new solutions in the service of animal health. In 1996 Vetoquinol UK entered the field of canine antiepileptic treatments with Epiphen tablets (phenobarbital) and followed this with the launch of Epiphen solution in 2002. Vetoquinol UK supports education and training in epilepsy in a number of ways including providing training days for veterinary surgeons, telephone based technical support and the sponsorship of a resident neurologist at the Animal Health Trust

The Animal Health Trust

AHT Logo
The Animal Health Trust (“AHT”) was founded in 1942 as the Veterinary Education Trust by a veterinary surgeon, Dr W R Wooldridge, who saw the human advances being made in medicine and wanted to apply them for the benefit of animals. Bringing veterinary surgeons closer to an understanding of disease would, he believed, be of enormous benefit to animals of all species, and by the 1960’s the AHT consisted of four establishments focusing on diseases of small animals, horses, livestock and poultry.

Throughout its existence the AHT, which was awarded its Royal Charter in 1963, has been a pioneer in the diagnosis and treatment of animal disease and its efforts are now concentrated on the prevention and cure of disease in companion animals and horses.

The Neurology Unit at the AHT offers a comprehensive referral service for canine and feline patients with neurological problems or myopathies. The excellent facilities, including on-site MRI, electrodiagnostic capabilities and neurosurgical operating equipment, with related oncology and other services, allow a standard of investigation and treatment matched by few other centres in the UK. The particular interests of the Neurology Unit include investigation and treatment of intracranial, vestibular and spinal disorders and myopathies. The Unit also prides itself on the maintenance of the congenital deafness screening programme in a variety of at-risk breeds.

Dechra

A business unit of Dechra Pharmaceuticals PLC, Dechra Veterinary Products specialises in the development and marketing of licensed branded pharmaceuticals and specialist premium pet foods for companion animals in the global veterinary market. Our key areas of expertise span dermatology, endocrinology, equine medicine, ophthalmology, critical care and diet and nutrition. We’re committed to developing new products and services that support the work of veterinary professionals and enhance the lives of their patients. Dechra will continue to invest in products and added-value services that deliver our promise to veterinary professionals and pet owners.

Under the name Genitrix, Dechra produce Libromide for use as an anti-epileptic therapy adjunct to phenobarbital in refractory cases of epilepsy in dogs.